Sterling Pharma Solutions
Sterling is a contract development and manufacturing organisation (CDMO). We provide full-service API development, scale up and cGMP contract manufacturing services from grams to tonnes, combined with Antibody Drug Conjugate (ADC) research and development bioconjugation services.
More Than Molecules | Sterling Pharma Solutions
Western drug substance manufacturing you can rely on - Sterling Pharma Solutions
Quality from the start: A deep dive into analytical method development
Facility overview - Newcastle Biosphere, UK - Sterling Pharma Solutions
Facility overview - North Carolina, US - Sterling Pharma Solutions
Analytical spotlight: A look at key methods
Anaerobic digestion plant overview
Facility overview - Cramlington, UK - Sterling Pharma Solutions
Facility overview - Cork, Ireland - Sterling Pharma Solutions
Facility overview - Wisconsin, US - Sterling Pharma Solutions
Facility overview - Deeside, UK - Sterling Pharma Solutions
(Mini webinar) Elevating your approach to high potency APIs
(Mini webinar) Integrated services for achieving the optimal solid form
Harnessing analytical chemistry in ADC development
Overcoming genotoxic impurities through a robust analytical approach
(Mini webinar) The rise of flow chemistry in API development and manufacturing
Phase I ADC development and manufacturing: A case study
API Solid State: The Challenges
An overview of CDMO, Sterling Pharma Solutions (2022)
The importance of a seasoned commercial partner: Successfully scaling your product
The use of mass spectrometry to aid ADC development
Complex chemistry at Sterling
ADC services at Sterling
Late phase API development and manufacturing at Sterling
Early phase API discovery and development at Sterling
Analytical chemistry at Sterling
Positioning your HPAPI programme for success
Biocatalysis webinar
Solid form: Why is it important to consider in API development
Biocatalysis: Using enzymes as catalysts